These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 14730096

  • 1. Synthesis, in vitro and in vivo 5-HT1A/5-HT2A serotonin receptor activity of new hybrid 1,2,3,4-tetrahydro-gamma-carbolines with 1-(2-methoxyphenyl)piperazine moiety.
    Boksa J, Charakchieva-Minol S, Duszyńska B, Bugno R, Kłodzińska A, Tatarczyńska E, Chojnacka-Wójcik E, Bojarski AJ.
    Pol J Pharmacol; 2003; 55(6):1013-9. PubMed ID: 14730096
    [Abstract] [Full Text] [Related]

  • 2. 2-H- and 2-acyl-9- [omega-[4-(2-methoxyphenyl)piperazinyl]-alkyl]-1,2,3,4-tetrahydro-beta-carbolines as ligands of 5-HT1A and 5-HT2A receptors.
    Boksa J, Mokrosz MJ, Charakchieva-Minol S, Tatarczyńska E, Kłodzińska A, Wesołowska A, Misztal S.
    Pol J Pharmacol; 2001; 53(5):501-8. PubMed ID: 11990069
    [Abstract] [Full Text] [Related]

  • 3. Novel 4-alkyl-1-arylpiperazines and 1,2,3,4-tetrahydroisoquinolines containing diphenylmethylamino or diphenylmethoxy fragment with differentiated 5-HT1A/5-HT2A/D2 receptor activity.
    Paluchowska MH, Mokrosz MJ, Charakchieva-Minol S, Duszyńska B, Kozioł A, Wesołowska A, Stachowicz K, Chojnacka-Wójcik E.
    Pol J Pharmacol; 2003; 55(4):543-52. PubMed ID: 14581712
    [Abstract] [Full Text] [Related]

  • 4. 9-substituted 1,2,3,4-tetrahydro-beta-carbolin-1-ones, new 5-HT1A and 5-HT2A receptor ligands.
    Mokrosz MJ, Boksa J, Charakchieva-Minol S, Wesołowska A, Borycz J.
    Pol J Pharmacol; 1999; 51(4):351-6. PubMed ID: 10540967
    [Abstract] [Full Text] [Related]

  • 5. New 4-[omega-(diarylmethylamino)alkyl]- and 4-[omega-(diarylmethoxy)alkyl]-1-arylpiperazines as selective 5-HT1A/5-HT2A receptor ligands with differentiated in vivo activity.
    Paluchowska MH, Charakchieva-Minol S, Tatarczyńska E, Kłodzińska A, Stachowicz K, Chojnacka-Wójcik E.
    Pol J Pharmacol; 2004; 56(6):743-54. PubMed ID: 15662087
    [Abstract] [Full Text] [Related]

  • 6. 1,4-Benzoxazin-3(4H)-one derivatives and related compounds as 5-HT1A and 5-HT2A receptor ligands; the effect of the terminal amide fragment on the 5-HT1A/5-HT2A affinity and functional activity.
    Mokrosz MJ, Kowalski P, Kowalska T, Majka Z, Duszyńska B, Charakchieva-Minol S, Szaro A, Tatarczyńska E, Kłodzińska A, Chojnacka-Wójcik E.
    Pol J Pharmacol; 1998; 50(4-5):333-40. PubMed ID: 10091718
    [Abstract] [Full Text] [Related]

  • 7. Synthesis, 5-HT1A and 5-HT2A receptor activity of new 1-phenylpiperazinylpropyl derivatives with arylalkyl substituents in position 7 of purine-2,6-dione.
    Chloń G, Pawłowski M, Duszyńska B, Szaro A, Tatarczńska E, Kłodzińska AL, Chojnacka-Wójcik E.
    Pol J Pharmacol; 2001; 53(4):359-68. PubMed ID: 11990082
    [Abstract] [Full Text] [Related]

  • 8. 1-Aryl-4-(4-succinimidobutyl)piperazines and their conformationally constrained analogues: synthesis, binding to serotonin (5-HT1A, 5-HT2A, 5-HT7), alpha1-adrenergic, and dopaminergic D2 receptors, and in vivo 5-HT1A functional characteristics.
    Bojarski AJ, Paluchowska MH, Duszyńska B, Kłodzińska A, Tatarczyńska E, Chojnacka-Wójcik E.
    Bioorg Med Chem; 2005 Mar 15; 13(6):2293-303. PubMed ID: 15727878
    [Abstract] [Full Text] [Related]

  • 9. Synthesis of new hexahydro- and octahydropyrido[1,2-c]pyrimidine derivatives with an arylpiperazine moiety as ligands for 5-HT1A and 5-HT2A receptors. Part 4.
    Herold F, Król M, Kleps J, Nowak G.
    Eur J Med Chem; 2006 Jan 15; 41(1):125-34. PubMed ID: 16263195
    [Abstract] [Full Text] [Related]

  • 10. Substitution mode of the amide fragment in some new N-[omega-[4-(2-methoxyphenyl)piperazin-1-yl]alkyl]pyrid-2(1H)-ones and their 5-HT1A/5-HT2A activity.
    Paluchowska MH, Bugno R, Charakchieva-Minol S, Bojarski AJ, Wesołowska A.
    Pol J Pharmacol; 2001 Jan 15; 53(4):369-76. PubMed ID: 11990083
    [Abstract] [Full Text] [Related]

  • 11. Effect of the amide fragment on 5-HT1A receptor activity of some analogs of MP 3022.
    Paluchowska MH, Charakchieva-Minol S, Tatarczyńska E, Kłodzińska A.
    Pol J Pharmacol; 1999 Jan 15; 51(5):415-21. PubMed ID: 10817542
    [Abstract] [Full Text] [Related]

  • 12. New arylpiperazine 5-HT(1A) receptor ligands containing the pyrimido[2,1-f]purine fragment: synthesis, in vitro, and in vivo pharmacological evaluation.
    Jurczyk S, Kołaczkowski M, Maryniak E, Zajdel P, Pawłowski M, Tatarczyńska E, Kłodzińska A, Chojnacka-Wójcik E, Bojarski AJ, Charakchieva-Minol S, Duszyńska B, Nowak G, Maciag D.
    J Med Chem; 2004 May 06; 47(10):2659-66. PubMed ID: 15115407
    [Abstract] [Full Text] [Related]

  • 13. Structure-activity relationship studies of CNS agents. Part 24: New analogs of N-tert.-butyl-3-[4-(2-methoxyphenyl)-1-piperazinyl]-2-phenylpropanamide (WAY-100135).
    Boksa J, Klodzińska A, Charakchieva-Minol S, Chojnacka-Wójcik E, Mokrosz JL.
    Pharmazie; 1996 Feb 06; 51(2):72-6. PubMed ID: 8720802
    [Abstract] [Full Text] [Related]

  • 14. Anxiolytic-like effect of a serotonergic ligand with high affinity for 5-HT1A, 5-HT2A and 5-HT3 receptors.
    Delgado M, Caicoya AG, Greciano V, Benhamú B, López-Rodríguez ML, Fernández-Alfonso MS, Pozo MA, Manzanares J, Fuentes JA.
    Eur J Pharmacol; 2005 Mar 21; 511(1):9-19. PubMed ID: 15777774
    [Abstract] [Full Text] [Related]

  • 15. Structure-affinity relationship study on N-(1,2,3,4-tetrahydronaphthalen-1-yl)-4-aryl-1-piperazinealkylamides, a new class of 5-hydroxytryptamine7 receptor agents.
    Leopoldo M, Berardi F, Colabufo NA, Contino M, Lacivita E, Niso M, Perrone R, Tortorella V.
    J Med Chem; 2004 Dec 16; 47(26):6616-24. PubMed ID: 15588097
    [Abstract] [Full Text] [Related]

  • 16. Influence of the aliphatic spacer length on the 5-HT1A receptor activity of new arylpiperazines with an indazole system.
    Paluchowska MH, Duszyńska B, Kłodzińska A, Tatarczyńska E.
    Pol J Pharmacol; 2000 Dec 16; 52(3):209-16. PubMed ID: 11055578
    [Abstract] [Full Text] [Related]

  • 17. Synthesis and 5-HT1A/5-HT2A receptor activity of new N-[3-(4-phenylpiperazin-1-yl)-propyl] derivatives of 3-spiro-cyclohexanepyrrolidine-2,5-dione and 3-spiro-beta-tetralonepyrrolidine-2,5-dione.
    Obniska J, Pawłowski M, Kołaczkowski M, Czopek A, Duszyńska B, Klodzińska A, Tatarczyńska E, Chojnacka-Wójcik E.
    Pol J Pharmacol; 2003 Dec 16; 55(4):553-7. PubMed ID: 14581713
    [Abstract] [Full Text] [Related]

  • 18. Synthesis and structure-activity relationships of a new model of arylpiperazines. 4. 1-[omega-(4-Arylpiperazin-1-yl)alkyl]-3-(diphenylmethylene) - 2, 5-pyrrolidinediones and -3-(9H-fluoren-9-ylidene)-2, 5-pyrrolidinediones: study of the steric requirements of the terminal amide fragment on 5-HT1A affinity/selectivity.
    López-Rodríguez ML, Morcillo MJ, Rovat TK, Fernández E, Vicente B, Sanz AM, Hernández M, Orensanz L.
    J Med Chem; 1999 Jan 14; 42(1):36-49. PubMed ID: 9888831
    [Abstract] [Full Text] [Related]

  • 19. Novel N-[omega-[4-(2-methoxyphenyl)piperazin-1-yl]-ethyl]pyrid-2(1H)-ones with diversified 5-HT1A receptor activity.
    Paluchowska MH, Bugno R, Charakchieva-Minol S, Wesołowska A, Chojnacka-Wójcik E.
    Pol J Pharmacol; 2002 Jan 14; 54(6):641-6. PubMed ID: 12866719
    [Abstract] [Full Text] [Related]

  • 20. New 5-hydroxytryptamine(1A) receptor ligands containing a norbornene nucleus: synthesis and in vitro pharmacological evaluation.
    Fiorino F, Perissutti E, Severino B, Santagada V, Cirillo D, Terracciano S, Massarelli P, Bruni G, Collavoli E, Renner C, Caliendo G.
    J Med Chem; 2005 Aug 25; 48(17):5495-503. PubMed ID: 16107148
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.